Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.40 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL669922 | 1.00 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| SCHEMBL670608 | 1.00 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| Hydrochloric Acid SCHEMBL670045 | 0.99 | SMN1; SMN2 (0.44) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| Hydrochloric Acid SCHEMBL16742846 | 0.99 | SMN1; SMN2 (0.44) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| SCHEMBL15109995 | 0.82 | BCL2 (0.55) | SMN1; SMN2 | |
| SCHEMBL2558812 | 0.81 | SMN1; SMN2 (0.45) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL2554080 | 0.81 | SMN1; SMN2 (0.45) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL354856 | 0.79 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| SCHEMBL117975 | 0.79 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| SCHEMBL18897543 | 0.79 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3063125-A1 | NOVEL INTERMEDIATE OF TAPENTADOL | Sun Pharma Advanced Research Company (IN) | 2016-09-07 | — | — | EP | claimed |
| WO-2015075744-A1 | NOVEL INTERMEDIATE OF TAPENTADOL | SUN PHARMA ADVANCED RESEARCH COMPANY (IN) | 2015-05-28 | — | — | WO | claimed |
| WO-2013105109-A1 | PROCESS FOR THE PREPARATION OF TAPENTADOL | INDOCO REMEDIES LIMITED (IN) | 2013-07-18 | — | — | WO | claimed |
| EP-2545028-A1 | A NOVEL STEREOSPECIFIC SYNTHESIS OF (-) (2S,3S)-1-DIMETHYLAMINO-3-(3-METHOXYPHENYL)-2-METHYL PENTAN-3-OL | Symed Labs Limited (IN) | 2013-01-16 | — | — | EP | claimed |
| EP-2542521-A2 | IMPROVED RESOLUTION METHODS FOR ISOLATING DESIRED ENANTIOMERS OF TAPENTADOL INTERMEDIATES AND USE THEREOF FOR THE PREPARATION OF TAPENTADOL | Actavis Group Ptc Ehf (IS) | 2013-01-09 | — | — | EP | claimed |
| WO-2012101649-A1 | A NOVEL STEREOSPECIFIC SYNTHESIS OF (-) (2S,3S)-1-DIMETHYLAMINO-3-(3-METHOXYPHENYL)-2-METHYL PENTAN-3-OL | SYMED LABS LIMITED (IN) | 2012-08-02 | — | — | WO | claimed |
| WO-2011107876-A2 | IMPROVED RESOLUTION METHODS FOR ISOLATING DESIRED ENANTIOMERS OF TAPENTADOL INTERMEDIATES AND USE THEREOF FOR THE PREPARATION OF TAPENTADOL | ACTAVIS GROUP PTC EHF (IS) | 2011-09-09 | — | — | WO | claimed |
| US-7410965-B2 | Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol | GRUENENTHAL GMBH (DE) | 2008-08-12 | — | — | US | claimed |
| EP-3063125-A1 | NOVEL INTERMEDIATE OF TAPENTADOL | Sun Pharma Advanced Research Company (IN) | 2016-09-07 | — | — | EP | disclosed |
| WO-2015075744-A1 | NOVEL INTERMEDIATE OF TAPENTADOL | SUN PHARMA ADVANCED RESEARCH COMPANY (IN) | 2015-05-28 | — | — | WO | disclosed |
| WO-2015075678-A1 | A NOVEL PROCESS FOR THE PREPARATION OF 1-PHENYL-3-AMINOPROPANE DERIVATIVES | UNIMARK REMEDIES LTD. (IN) | 2015-05-28 | — | — | WO | disclosed |
| WO-2013111161-A2 | PROCESS FOR THE PREPARATION OF 3-ARYL-2-METHYL-PROPANAMINE DERIVATIVES AND POLYMORPHS THEREOF | MSN LABORATORIES LIMITED (IN) | 2013-08-01 | — | — | WO | disclosed |
| EP-2619174-A1 | PROCESS FOR PREPARING L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVE | Ind-Swift Laboratories Limited (IN) | 2013-07-31 | — | — | EP | disclosed |
| WO-2013105109-A1 | PROCESS FOR THE PREPARATION OF TAPENTADOL | INDOCO REMEDIES LIMITED (IN) | 2013-07-18 | — | — | WO | disclosed |
| EP-1507519-A1 | MEDICAMENT WITH DELAYED RELEASE OF THE ACTIVE SUBSTANCE, CONTAINING 1-DIMETHYLAMINO-3-(3-METHOXY-PHENYL)-2-METHYL-PENTAN-3-OL | Grünenthal GmbH (DE) | 2005-02-23 | — | — | EP | disclosed |
| EP-1507521-A1 | METABOLITE OF 1-DIMETHYLAMINO-3-(3-METHOXY-PHENYL)-2-METHYL-PENTANE-3-OL AND THE USE THEREOF IN THE TREATMENT OF URINARY INCONTINENCE | Grünenthal GmbH (DE) | 2005-02-23 | — | — | EP | disclosed |
| EP-1429754-A1 | COMBINATION OF SELECTED OPIOIDS WITH MUSCARINE ANTAGONISTS FOR TREATING URINARY INCONTINENCE | Grünenthal GmbH (DE) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003101440-A1 | METABOLITE OF 1-DIMETHYLAMINO-3-(3-METHOXY-PHENYL)-2-METHYL-PENTANE-3-OL AND THE USE THEREOF IN THE TREATMENT OF URINARY INCONTINENCE | Grünenthal GmbH (DE) | 2003-12-11 | — | — | WO | disclosed |
| WO-2003099267-A1 | MEDICAMENT WITH DELAYED RELEASE OF THE ACTIVE SUBSTANCE, CONTAINING 1-DIMETHYLAMINO-3-(3-METHOXY-PHENYL)-2-METHYL-PENTAN-3-OL | Grünenthal GmbH (DE) | 2003-12-04 | — | — | WO | disclosed |
| WO-2003024444-A1 | COMBINATION OF SELECTED OPIOIDS WITH MUSCARINE ANTAGONISTS FOR TREATING URINARY INCONTINENCE | Grünenthal GmbH (DE) | 2003-03-27 | — | — | WO | disclosed |